Dr. Jain, a medical oncologist/hematologist specializing in gastrointestinal and genitourinary oncology, sees NET patients who have been diagnosed by biopsy as well as individuals seeking a diagnosis.  At Rush, she is part of both GI and neuroendocrine tumor boards that meet weekly to monthly to discuss the treatment and follow-up of NET patients. She is active in clinical trials and research looking at outcomes of PRRT and the utility of dotatate scans in different scenarios. Her clinical focus is GI oncology with a special interest in neuroendocrine tumors.  Her research interests include neuroendocrine tumors, precision oncology, immunotherapy, genomics, colorectal and pancreatic cancers, hepatocellular carcinoma and advances in cancer therapy.  She has several papers published in peer-reviewed journals.  Her research interests also include gender equity and career advancement for women and underrepresented minorities in medicine, the impact of social media on medicine.

Source: Shikha Jain, MD (Medical Oncology/Hematology) – Carcinoid Cancer Foundation